Purchase Order VA24717P1127
- Not listed
- This federal contract award is for the delivery of HIV reagents to the Department of Veterans Affairs (VA) Veterans Health Administration. The $117,225.68 firm fixed-price contract was awarded to Roche Diagnostics Corporation, a foreign-owned manufacturer of in vitro diagnostics, laboratory instruments, and related products and services. The contract was issued through the VA's Veterans Integrated Service Network 4 and is not designated as a set-aside. Roche Diagnostics holds multiple General...
- This federal contract award, valued at $163,341.11, was made by the Veterans Integrated Service Network 4 (VISN 4) of the U.S. Department of Veterans Affairs (VA) to Roche Diagnostics Corporation, a manufacturer and distributor of in vitro diagnostics, reagents, laboratory instruments, and related products and services. The award is for the provision of HCV and HIV reagent kits, which are critical for patient care and testing at VA hospitals and clinics. The contract is a Blanket Purchase...
- This federal contract award to Roche Diagnostics Corporation (Roche), a manufacturer and distributor of in vitro diagnostics, provides the Department of Veterans Affairs (VA) with COBAS AMPLIPREP/COBAS TAQMAN HCV V 2.0 and COBAS AMPLIPREP/COBAS TAQMAN HIV-1 V.2.0 test kits. The $542,265.60 firm fixed-price purchase order has a completion date of May 31, 2017. Roche has been awarded multiple federal contracts and indefinite delivery vehicles (IDVs) to supply laboratory instruments, reagents, test...
- This federal contract was awarded by the Department of Veterans Affairs (VA) Veterans Integrated Service Network 4 to Roche Diagnostics Corporation, a foreign-owned for-profit manufacturer of in vitro diagnostics, reagents, and laboratory instruments. The contract is for the procurement of Roche Cobas 6800 HIV/HCV testing systems and associated reagents, with a ceiling value of $3,414,915.46. The contract has a five-year period of performance from June 12, 2020 to June 12, 2025, and does not...
- The Department of Veterans Affairs Veterans Health Administration awarded a $118,415.04 firm-fixed-price delivery order to Roche Diagnostics Corporation, a foreign-owned for-profit manufacturer, to provide reagents and supplies needed to perform HIV, HBV, and HCV (molecular) testing. The contract was awarded through the GSA's Critical Analyzers, Laboratory (FSS-66-III) schedule and does not have a set-aside designation. Roche Diagnostics has provided similar laboratory equipment, reagents, and...
- The Department of Veterans Affairs Veterans Health Administration awarded a firm-fixed-price delivery order contract to Roche Diagnostics Corporation, doing business as Roche Diagnostics Corp, to provide HIV and HCV reagents, supplies, and instrument service. The $423,902.51 contract was issued under Roche's General Services Administration (GSA) Schedule 66-III for Critical Analyzers and Laboratory Equipment. Roche, a foreign-owned for-profit manufacturer, has provided similar medical devices,...
- The Department of Veterans Affairs (VA) awarded a $346,183.99 firm-fixed-price delivery order to Roche Diagnostics Corporation for reagents, supplies, and instrument service for hepatitis C (HCV) and HIV testing. The order was placed against Roche's General Services Administration (GSA) Federal Supply Schedule contract for critical laboratory analyzers and equipment. The contract does not have a set-aside designation. This delivery order supports the VA's Veterans Health Administration and its...
- This is a delivery order awarded by the Department of Veterans Affairs (VA) Veterans Health Administration to Roche Diagnostics Corporation, doing business as Roche Diagnostics Corp, for the supply of hepatitis B virus (HBV), hepatitis C virus (HCV), and human immunodeficiency virus (HIV) reagents, consumables, and supplies needed to perform tests on Roche Cobas equipment. The $514,452.31 firm fixed-price contract does not have a set-aside designation and was awarded on September 29, 2017 with a...
- This federal contract award was issued by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 12 to Roche Diagnostics Corporation, a manufacturer and distributor of in vitro diagnostics, reagents, laboratory instruments, and associated products and services. The $305,417.32 Firm Fixed Price Delivery Order is for the provision of HIV/HBV molecular pathology reagents, with a completion date of March 31, 2020. The contract was issued under Roche's...
- This federal contract award was issued by the Department of Veterans Affairs (VA) Veterans Health Administration to Roche Diagnostics Corporation, a manufacturer and distributor of in vitro diagnostics, reagents, laboratory instruments, and associated products and services. The contract, valued at $429,523.25, is a Blanket Purchase Agreement (BPA) call for HCV/HIV cost per test services during Fiscal Year 2018. The contract has no set-aside designation and is under Roche's General Services...
This is a firm fixed-price purchase order awarded by the Department of Veterans Affairs (VA) to Roche Diagnostics Corporation, a manufacturer of in vitro diagnostics, reagents, and laboratory equipment. The $5,478,780.08 contract is for the provision of Roche Cobas 6800 HCV and HIV reagents. This award is not associated with a set-aside program. Roche Diagnostics has extensive experience as a prime contractor and subcontractor providing medical equipment, supplies, and services to various federal agencies, including the VA, Department of Defense, and Department of Health and Human Services. The company holds multiple General Services Administration (GSA) Schedule contracts as well as Indefinite Delivery Contracts and Blanket Purchase Agreements with government customers to streamline the acquisition of its products and services. This specific award supports the VA's need for viral testing capabilities, likely to benefit veterans, active duty personnel, and other eligible patients at VA healthcare facilities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00013 | Other Administrative Action | ($597k) | 6/23/22 | |
| P00012 | Other Administrative Action | ($96k) | 4/6/21 | |
| P00011 | Other Administrative Action | ($101k) | 3/31/21 | |
| P00010 | Supplemental Agreement for work within scope | $32.8k | 3/10/21 | |
| P00009 | Exercise an Option | $1.6m | 3/9/21 |